ClearPoint Neuro/$CLPT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About ClearPoint Neuro
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
- Ticker
- $CLPT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 172
- Headquarters
- Solana Beach, United States
- Website
- www.clearpointneuro.com
ClearPoint Neuro Metrics
BasicAdvanced
$279M
-
-$1.21
1.29
-
Price and volume
Market cap
$279M
Beta
1.29
52-week high
$19.63
52-week low
$8.27
Average daily volume
783K
Financial strength
Current ratio
6.76
Quick ratio
5.492
Long term debt to equity
2.696
Total debt to equity
2.703
Interest coverage (TTM)
-5.69%
Profitability
EBITDA (TTM)
-29.024
Gross margin (TTM)
61.39%
Net profit margin (TTM)
-79.43%
Operating margin (TTM)
-66.60%
Effective tax rate (TTM)
0.08%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-21.88%
Return on equity (TTM)
-167.52%
Valuation
Price to revenue (TTM)
5.71
Price to book
10.21
Price to tangible book (TTM)
37.73
Price to free cash flow (TTM)
-7.819
Free cash flow yield (TTM)
-12.79%
Free cash flow per share (TTM)
-1.111
Growth
Revenue change (TTM)
32.51%
Earnings per share change (TTM)
46.29%
3-year revenue growth (CAGR)
26.79%
10-year revenue growth (CAGR)
23.25%
3-year earnings per share growth (CAGR)
10.80%
10-year earnings per share growth (CAGR)
-9.43%
What the Analysts think about ClearPoint Neuro
Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.
Analyst projections of the future price of ClearPoint Neuro stock.
ClearPoint Neuro Financial Performance
Revenues and expenses
ClearPoint Neuro Earnings Performance
Company profitability
Upcoming events
No upcoming events
ClearPoint Neuro News
AllArticlesVideos
What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call
MarketBeat1 week ago
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
Accesswire3 weeks ago
CLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS Law
Business Wire4 weeks ago
Funds containing ClearPoint Neuro
Fund name | Fund size | $CLPT weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.